Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Dermatology Guidelines
    • Use of local...

    Use of local anesthesia in office-based dermatologic surgery- Guidelines

    Written by supriya kashyap kashyap Published On 2016-11-19T09:13:59+05:30  |  Updated On 19 Nov 2016 9:13 AM IST
    Use of local anesthesia in office-based dermatologic surgery- Guidelines

    In the practice of medicine (especially surgery) and dentistry, anesthesia or anaesthesia is a temporary induced state with one or more of analgesia (relief from or prevention of pain), paralysis (muscle relaxation), amnesia (loss of memory), and unconsciousness. A patient under the effects of anesthetic drugs is referred to as being anesthetized.


    In July 2016, American Academy of Dermatology Guidelines for the use of local anesthesia in office-based dermatologic surgery. Following are the major recommendations:


    Recommendations for the Use of Topical Anesthesia in Dermatologic Surgery





    • Noncocaine formulations are preferred over cocaine formulations and recommended for use in office-based procedures.

    • Topical agents are recommended as a first-line method of anesthesia for nonablative laser treatments.

    • Topical anesthesia can be used for performing office-based procedures, such as skin biopsy, small excisions, and filler and botulinum toxin injections.

    • The use of topical anesthetic agents is recommended to lessen the pain of injection and reduce the dose of infiltration anesthesia needed for larger procedures.

    • Topical lidocaine is safe for use on pregnant or nursing women, but there is insufficient evidence to recommend use of other topical anesthetics.

      • Elective procedures and those not of urgent medical necessity requiring topical lidocaine in pregnant women should be postponed until after delivery.

      • Procedures of urgent medical necessity should be delayed until at least the second trimester when possible.



    • Topical agents are recommended as a first-line method of anesthesia for the repair of dermal lacerations in children and for other minor dermatologic procedures, including curettage. For skin biopsy, excision, or other cases where topical agents alone are insufficient, adjunctive use of topical anesthesia to lessen the discomfort of infiltrative anesthetic should be considered.

    • For more extensive surgery, the combination of topical and infiltration anesthesia should be considered as an alternate to sedation or general anesthesia in pediatric patients.


    Strength of Recommendations for Use of Topical Anesthesia in Dermatologic Surgery

































































    RecommendationStrength of RecommendationLevel of EvidenceReferences
    Use of noncocaine topical anestheticsAIIEidelman et al., 2005
    Topical anesthesia as the first-line method for nonablative laser treatmentsCIIIBryan & Alster, 2002; Kilmer et al., 2003
    Topical anesthesia for use in minor skin procedures in adultsCIIIBryan & Alster, 2002; Kilmer et al., 2003; Franchi et al., 2009; Jones & Nandapalan, 1999; Goodacre et al., 1988; Russell, Desmond, & Fox, 1988; Ferguson, Loryman, & Body, 2005; Hallen, Ljunghall, & Wallin, 1987; Gupta & Sibbald, 1996
    Topical anesthesia to reduce the pain of local anesthetic injectionCIIIExpert opinion
    Use of limited amounts of topical lidocaine in pregnant and nursing womenCIIIMurase, Heller, & Butler, 2014; Gormley, 1990; Richards & Stasko, 2002; Butler, Heller, & Murase, 2014
    Postpone use of topical anesthesia until after delivery or second trimester when possibleCIIIExpert opinion
    Against use of nonlidocaine topical anesthetics in pregnant or nursing womenCIIIExpert opinion
    Use of topical anesthesia as the first-line method for repair of dermal lacerations in childrenAI,IIFerguson, Loryman, & Body, 2005; Bonadio & Wagner, 1988; Hegenbarth et al., 1990; Smith et al., 1998; Smith et al., 1996; Smith & Barry, 1990; Zempsky & Karasic, 1997
    Use of topical anesthesia as the first-line method for other minor procedures in childrenCIIIExpert opinion
















    Adjunctive use of topical anesthesia to minimize discomfort of infiltrative anesthesia in childrenCIIIExpert opinion
    Topical and infiltrative anesthesia used as an alternate to sedation and general anesthesia in childrenCIIIFerguson, Loryman, & Body, 2005; Bonadio & Wagner, 1988; Hegenbarth et al., 1990; Smith et al., 1998; Smith et al., 1996; Smith & Barry, 1990; Zempsky & Karasic, 1997; Pierluisi & Terndrup, 1989; Priestley et al., 2003

    Recommendations for the Use of Local Infiltrative Anesthesia in Dermatologic Surgery



    • Infiltrative anesthesia is safe and recommended for office-based dermatologic procedures, including but not limited to obtaining a biopsy specimen, excision, wound closure, tissue rearrangement, skin grafting, cauterization, nonablative laser, and ablative skin resurfacing.

    • Infiltrative anesthesia may be combined with other forms of local anesthesia for larger or more complex cutaneous procedures, including but not limited to:

      • Full-face ablative laser resurfacing, combined with topical and nerve block anesthesia

      • Follicular unit hair transplantation, combined with tumescent local anesthesia.



    • The maximum safe dose of local infiltrated anesthesia is unknown.

    • For adults, no more than 4.5 mg/kg of lidocaine and 7.0 mg/kg of lidocaine with epinephrine should be administered in a single treatment.

    • For children, no more than 1.5-2.0 mg/kg of lidocaine and 3.0-4.5 mg/kg of lidocaine with epinephrine should be administered in a single treatment.

    • For a multistage procedure, such as Mohs micrographic surgery, a maximum dose of local infiltrative anesthesia of 50 mL of 1% lidocaine solution (500 mg) delivered over several hours is recommended.

    • Use of either ester-type local anesthetics, bacteriostatic normal saline, or 1% diphenhydramine is suggested as an alternate form of local infiltration anesthesia for patients with true allergy to lidocaine.

    • Steps recommended to decrease the risk of local anesthetic systemic toxicity:

      • Use the lowest effective dose of local anesthetic.

      • Aspirate the needle/catheter prior to each injection to avoid introducing the drug directly into a vessel.

      • Use incremental injections of anesthetic.

      • Continually assess and communicate with the patient to monitor for signs of early toxicity.




    Strength of Recommendations for the Use of Local Infiltrative Anesthesia in Dermatologic Surgery


































































    RecommendationStrength of RecommendationLevel of EvidenceReferences
    Use of local infiltrative anesthesia for obtaining a biopsy specimen, excision, wound closure, tissue rearrangement, skin grafting, cauterization, nonablative laser, and ablative skin resurfacingCIIIExpert opinion
    Combining methods of local anesthesia for full-face ablative laser and follicular unit hair transplantationCIIIExpert opinion
    Maximum dose of 4.5 mg/kg of lidocaine and 7.0 mg/kg of lidocaine with epinephrine for adultsCIIIHancox et al., 2004; Klein, 1993; Drake et al., 1995
    Maximum dose of 1.5-2.0 mg/kg of lidocaine and 3.0-4.5 mg/kg of lidocaine with epinephrine for childrenCIIIHancox et al., 2004
    Max dose of 500 mg of lidocaine for a multistage Mohs micrographic surgeryBIIAlam et al., 2010
    Use of ester type local anesthetics for patients with lidocaine allergyCIIIBhole et al., 2012
    Use of diphenhydramine for patients with lidocaine allergyCIIIGreen, Rothrock, & Gorchynski, 1994; Xia et al., 2002
    Use of bacteriostatic normal saline for patients with lidocaine allergyCIIIBartfield, Jandreau, & Raccio-Robak, 1998
    Prevention of local anesthetic systemic toxicityAI,IINeal et al., 2010; Neal, Mulroy, & Weinberg, 2012; Mercado & Weinberg, 2011

    Recommendations for Mixing and the Use of Additives to Local Infiltrative Anesthesia in Dermatologic Surgery


    Epinephrine

    • The addition of epinephrine to local infiltration anesthesia is safe and recommended for use on the ear, nose, hand, feet, and digits.

    • The addition of epinephrine to local infiltration anesthesia may be considered for use during procedures on the penis.

    • Local infiltrative anesthesia with epinephrine may be used in small amounts in women who are pregnant:

      • Elective procedures and those not of urgent medical necessity requiring lidocaine with epinephrine should be postponed until after delivery.

      • Procedures of urgent medical necessity should be delayed until the second trimester when possible.

      • In case of doubt, consult with the patient's obstetrician.



    • Local infiltrative anesthesia with epinephrine may be administered to patients with stable cardiac disease. If uncertain of a patient's ability to tolerate epinephrine, consult with the patient's cardiologist.

    • Use of the lowest effective concentration of epinephrine to provide pain control and vasoconstriction in local infiltrative anesthesia is recommended.


    Hyaluronidase

    • Hyaluronidase may be used as an additive to local infiltration anesthesia to ease diffusion and reduce contour distortion, yet there are insufficient data to support a recommendation for its routine use in dermatologic surgery.

    • Hyaluronidase should not be administered to patients with a known bee venom allergy.


    Buffering

    • The addition of sodium bicarbonate to local anesthetic, particularly lidocaine with epinephrine, is recommended to decrease the pain of delivery by subcutaneous or intradermal infiltration.

    • Preinjection of buffered lidocaine solution is suggested to reduce the pain of bupivacaine infiltration.


    Mixing Local Anesthetics

    It is unclear whether mixing multiple anesthetics for local infiltration poses further benefit over use of a single agent.

    Strength of Recommendations for Mixing and the Use of Additives to Local Infiltrative Anesthesia in Dermatologic Surgery

































































    RecommendationStrength of RecommendationLevel of EvidenceReferences
    Addition of epinephrine to local anesthesia on the ear, nose, and digitsAI,IIAltinyazar et al., 2004; Chowdhry et al., 2010; Denkler, 2001; Denkler, 2005; Häfner et al., 2008; Krunic et al., 2004; Lalonde et al., 2005; Radovic, Smith, & Shumway, 2003; Sonohata et al., 2012; Wilhelmi et al., 2001; Häfner, Rocken, & Breuninger, 2005
    Addition of epinephrine to local anesthesia on the penisBIISchnabl et al., 2014
    Addition of epinephrine to local anesthesia in women who are pregnant or nursingBIIMurase, Heller, & Butler, 2014
    Addition of epinephrine to local anesthesia in patients with stable cardiac diseaseBI,IISerrera Figallo et al., 2012; Niwa et al., 2001
    Addition of epinephrine to local infiltrative anesthesia at the lowest effective concentrationBII,IIIDunlevy, O'Malley, & Postma 1996; Gessler et al., 2001; Liu et al., 1995
    Against addition of hyaluronidase to local anesthesia in patients with bee venom allergyBIIKirby et al., 2001
    Against use of hyaluronidase to reduce tissue distortion and improve underminingCIIIClark & Mellette, 1994; Landsman & Mandy, 1991
    Addition of sodium bicarbonate to reduce pain of local anesthetic infiltrationAI.IIMasters, 1998; Stewart et al., 1990; Stewart, Cole, & Klein, 1989; Welch et al., 2012; Burns et al., 2006
    Preinjection of buffered lidocaine to reduce pain of bupivacaine injectionCIIIExpert opinion










    Mixing multiple anesthetics for the same procedureCIIGadsden et al., 2011; Lai, Sutton, & Nicholson, 2003; Nicholson, Sutton, & Hall, 2000; Ozdemir et al., 2004; Ribotsky, Berkowitz, & Montague, 1996; Seow et al., 1982; Sweet, Magee, & Holland, 1982; van den Berg & Montoya-Pelaez, 2001

    Recommendations for Minimizing Pain of Administration of Local Infiltration Anesthesia and Alternate Methods of Analgesia in Dermatologic Surgery



    • Slow rate of infiltration, vibration of the skin, use of a warm solution, or cold air skin cooling should be considered to decrease the pain of local anesthetic injection.

    • It is unclear whether pretreatment with ethyl chloride spray, preinjection with normal saline, or verbal distraction decreases the pain of local anesthetic infiltration.

    • There is contradictory evidence regarding the effectiveness of ethyl chloride, and its use as a sole method for analgesia in dermatologic procedures should not be considered.

    • Cold air skin cooling may be considered to reduce patient discomfort during nonablative laser therapy.

    • Use of a skin-vibrating device may be considered to help decrease the pain of botulinum toxin injection.


    Strength of Recommendations for Minimizing Pain of Administration of Local Infiltration Anesthesia and Alternate Methods of Analgesia in Dermatologic Surgery









































    RecommendationStrength of RecommendationLevel of EvidenceReferences
    Slow rate of infiltration, vibration of the skin, use of a warm solution, and cold air skin cooling are recommended to decrease the pain of local anesthetic injection.BIIFosko, Gibney, & Harrison, 1998; Kaplan & Moy, 1996; Scarfone, Jasani, & Gracely, 1998; Al-Qarqaz et al., 2012; Fayers, Morris, & Dolman, 2010
    Pretreatment with ethyl chloride spray, preinjection with normal saline, or verbal distraction to decrease the pain of local anesthetic infiltrationCIIIExpert opinion; Swinehart, 1992
    Ethyl chloride as an analgesic for dermatologic procedures.CIIIArmstrong, Young, & McKeown, 1990; Robinson et al., 2007; Selby & Bowles, 1995; Soueid & Richard, 2007; Yoon et al., 2008; White et al., 1999
    Cold air skin cooling to reduce patient discomfort during nonablative laser therapyBIIHammes & Raulin, 2005; Raulin, Greve, & Hammes, 2000
    Use of a skin-vibrating device to decrease the pain of botulinum toxin injection into glabellar rhytidesBIISharma, Czyz, & Wulc, 2011


    Recommendations for Nerve Blocks in Dermatologic Surgery



    • Regional cutaneous nerve block anesthesia is recommended for ablative laser resurfacing of the face and botulinum toxin injection of the palm

    • Nerve block should be considered as an alternative or in addition to infiltrative anesthesia for procedures on the face, hands, feet, and digits, and may provide the benefit of decreased tissue swelling/distortion, prolong anesthesia, and reduce postoperative discomfort for the patient


    Strength of Recommendations for Nerve Blocks in Dermatologic Surgery























    RecommendationStrength of RecommendationLevel of EvidenceReferences
    Nerve block anesthesia for ablative laser resurfacing of the face, botulinum toxin injection of the palm, and upper lid ptosis surgeryBIILee, Khandwala, & Jones, 2009; Hund et al., 2004; Vadoud-Seyedi, Heenen, & Simonart, 2001; Wan et al., 2013
    Nerve block as an alternate to local infiltration anesthesia for dermatologic surgery on the face and digitsCIIIExpert opinion

    Recommendations for Tumescent Local Anesthesia in Dermatologic Surgery



    • Lidocaine and prilocaine are both safe and recommended for use in tumescent local anesthesia for office-based liposuction. Bupivacaine is not recommended for this use.

    • Use of prilocaine is not approved in the United States for this procedure as of the date of this publication.

    • The addition of epinephrine to lidocaine is recommended and safe for use in tumescent local anesthesia for liposuction.

    • A maximum dose of 55 mg/kg of lidocaine with epinephrine has been shown to be safe and can be used for tumescent local anesthesia for liposuction in patients weighing 43.6-81.8 kg.

    • The use of warm anesthetic solution and a slow infiltration rate is recommended to decrease patient discomfort during administration of tumescent local anesthesia.


    Strength of Recommendations for Tumescent Local Anesthesia in Dermatologic Surgery









































    RecommendationStrength of RecommendationLevel of EvidenceReferences
    Lidocaine and prilocaine for use in tumescent local anesthesia for office-based liposuctionAI,IIKlein, 1990; Burk, Guzman-Stein, & Vasconez, 1996; Glowacka et al., 2009; Habbema, 2010; Lillis, 1988; Rubin et al., 1999; Augustin et al., 2010; Breuninger & Wehner-Caroli, 1998; Lindenblatt et al., 2004
    The addition of epinephrine to lidocaine for use in tumescent local anesthesia for liposuctionAI,IIKlein, 1990; Burk, Guzman-Stein, & Vasconez, 1996; Glowacka et al., 2009; Habbema, 2010; Lillis, 1988; Rubin et al., 1999
    A maximum dose of 55 mg/kg of lidocaine with epinephrine for local tumescent anesthesia for liposuctionAIOstad, Kageyama, & Moy, 1996
    Use of a warm solution to decrease patient discomfort during administration of tumescent local anesthesiaBIIKaplan & Moy, 1996
    Use of a slow infiltration rate to decrease patient discomfort during administration of tumescent local anesthesiaBIIIHanke, et al., 1997

    You can read the full Guidelines on clicking on the link :

    Kouba DJ, LoPiccolo MC, Alam M, Bordeaux JS, Cohen B, Hanke CW, Jellinek N, Maibach HI, Tanner JW, Vashi N, Gross KG, Adamson T, Begolka WS, Moyano JV. Guidelines for the use of local anesthesia in office-based dermatologic surgery. J Am Acad Dermatol. 2016 Jun;74(6):1201-19. [141 references]
    dermatologic surgeryguideline on anesthesiaHyaluronidaseloss of memoryunconsciousness

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok